The FDA has granted an emergency use authorization (EUA) to Regeneron Pharmaceuticals’ two-antibody “cocktail” REGEN-COV2 (formerly REGN-COV2) as a treatment for adults and youths ages 12 years and older with mild-to-moderate COVID-19.
Regulators advise resident time distribution (RTD) studies as a way to address issues between batch processing and continuous manufacturing of biologics.
When testing sensors in upstream bioprocessing, electrochemical sensors were more accurate than optical pH sensors, but less accurate as a batch of cells aged.
Workflow design and data management are pivotal components of cell and gene therapy research and development. Advances in artificial intelligence, informatics, and automation have made…
A new study has identified differential gene-network changes characteristic of the three most prevalent molecular subtypes of breast cancer, Luminal A, Luminal B, and the…
From the keynotes to the tracks, conversations around AI-based applications were top of mind at this year’s meeting.
In this webinar, Jeff Coller, PhD, will describe a new therapeutic technique that enhances mRNA translation. This technology has numerous clinical applications and works by…
Researchers say there is little chance of a virus mutating to avoid this vaccination strategy, which blocks viral ability to suppress host RNAi responses.
Researchers say there is little chance of a virus mutating to avoid this vaccination strategy, which blocks viral ability to suppress host RNAi responses.
By capturing the genotypic and phenotypic heterogeneity of real tissues, organoids faithfully model human diseases and therapeutic responses.
A new study shows tetracycline antibiotics help the immune system find cancer cells in a way that is different from current immunotherapies.
